Exact Mass: 394.0786

Diflufenican

C19H11F5N2O2 (394.0741)

CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5369; ORIGINAL_PRECURSOR_SCAN_NO 5368 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5374; ORIGINAL_PRECURSOR_SCAN_NO 5371 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5368; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5376; ORIGINAL_PRECURSOR_SCAN_NO 5375 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5337; ORIGINAL_PRECURSOR_SCAN_NO 5333 CONFIDENCE standard compound; INTERNAL_ID 4010 CONFIDENCE standard compound; INTERNAL_ID 2315 CONFIDENCE standard compound; INTERNAL_ID 8384

5-Butyrylphosphouridine

C13H19N2O10P (394.0777)

Prostalidin A

C21H14O8 (394.0689)

Tetracenomycin B3

C21H14O8 (394.0689)

Tetracenomycin D3 methylester

C21H14O8 (394.0689)

Sch 50673

C21H14O8 (394.0689)

58G

C21H14O8 (394.0689)

Demethyltorosaflavone C

C21H14O8 (394.0689)

Newbouldiaquinone

C25H14O5 (394.0841)

FL 120B

C20H14N2O7 (394.0801)

Maybridge1_008234

C16H12F6N2O3 (394.0752)

Oprea1_016573

C18H20Cl2N4S (394.0786)

Q63409042

C21H14O8 (394.0689)

Hexsose + C5H10O3, 1phosphate

C11H23O13P (394.0876)

Annotation level-3

Preussomerin I

C21H14O8 (394.0689)

oxalicumone E

C18H18O8S (394.0722)

SCHEMBL16226573

C21H14O8 (394.0689)

methyl 5-chloro-4-O-demethylbarbatate|metyl 5-chloro-4-O-demethylbarbatate

C19H19ClO7 (394.0819)

10-Bromo-7,12-diacetoxy-Delta2,3-lauren

C19H23BrO4 (394.078)

Antibiotic FL 120B|FL-120B

C20H14N2O7 (394.0801)

Diflufenican

C19H11F5N2O2 (394.0741)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 116

Daphnoretine Acetate

C21H14O8 (394.0689)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102

7-O-acetyldaphnoretin

C21H14O8 (394.0689)

Origin: Plant, Coumarins

sanguinarine nitrate

C20H14N2O7 (394.0801)

2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE

C18H19ClN2O4S (394.0754)

Gonyautoxin II

C10H16N7O8S (394.0781)

From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.

DPPH

C18H12N5O6 (394.0788)

2-(2,4-dichlorophenoxy)-N-[4-(morpholin-4-ylmethyl)phenyl]acetamide

C19H20Cl2N2O3 (394.0851)

4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide

C19H14N4O4S (394.0736)

4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H20Cl2N4S (394.0786)

Aklanonate(2-)

C21H14O8-2 (394.0689)

1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone

C18H19FN2O3S2 (394.0821)

N,N-diethyl-2-[(4-fluorophenyl)methylthio]-1,3-benzoxazole-5-sulfonamide

C18H19FN2O3S2 (394.0821)

7-chloro-4-[(2-fluorophenyl)-oxomethyl]-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one

C22H16ClFN2O2 (394.0884)

N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide

C21H15ClN2O4 (394.072)

3-Tosyloxyflavanone

C22H18O5S (394.0875)

ARN19874

C19H14N4O4S (394.0736)

ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].

{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate

C19H23BrO4 (394.078)

[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate

C19H23BrO4 (394.078)

(3s,4s,6r,7r)-9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate

C20H14N2O7 (394.0801)

(3r,4r,6s,7s)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate

C20H14N2O7 (394.0801)

6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate

C21H14O8 (394.0689)

methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

C21H14O8 (394.0689)

9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate

C20H14N2O7 (394.0801)

(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

C21H14O8 (394.0689)

(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid

C21H14O8 (394.0689)

1-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2-methylanthracene-9,10-dione

C25H14O5 (394.0841)

methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate

C21H14O8 (394.0689)

(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione

C21H14O8 (394.0689)

1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate

C18H18O8S (394.0722)

(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione

C21H14O8 (394.0689)

(3s,4s,6r,7r)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate

C20H14N2O7 (394.0801)

(3s,4s,6r,7r)-7-(acetyloxy)-9-(diazyn-1-ium-1-yl)-3,13-dihydroxy-6-methyl-11-oxo-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(18),2(8),9,12,14,16-hexaen-18-olate

C20H14N2O7 (394.0801)

1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

C18H18O8S (394.0722)

3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate

C20H14N2O7 (394.0801)

1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate

C18H18O8S (394.0722)